title: Prevention of preeclampsia.
abstract: Preeclampsia (PE) affects around 2-5% of pregnant women. It is a major cause of maternal and perinatal morbidity and mortality. In an attempt to prevent preeclampsia, many strategies based on antenatal care, change in lifestyle, nutritional supplementation, and drugs have been studied. The aim of this paper is to review recent evidence about primary and secondary prevention of preeclampsia.
authors: Department of Public Health, State University of Ceara, 60.740-000 Fortaleza, CE, Brazil.
authors: Sammya
authors: S
authors: Bezerra Maia E Holanda Moura
authors: Laudelino
authors: L
authors: Marques Lopes
authors: Padma
authors: P
authors: Murthi
authors: Fabricio
authors: F
authors: da Silva Costa
mesh_terms: D000975:Antioxidants / Q000627:therapeutic use; D001510:Bed Rest; D002118:Calcium / Q000627:therapeutic use; D004039:Diet, Sodium-Restricted; D019587:Dietary Supplements; D004232:Diuretics / Q000627:therapeutic use; D005081:Exercise Therapy; D005260:Female; D006801:Humans; D020030:Nitric Oxide Donors / Q000627:therapeutic use; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D011225:Pre-Eclampsia / Q000517:prevention & control*; D011247:Pregnancy; D011295:Prenatal Care / Q000379:methods*; D011322:Primary Prevention / Q000379:methods*; D011374:Progesterone / Q000627:therapeutic use; D011372:Progestins / Q000627:therapeutic use; D055502:Secondary Prevention / Q000379:methods*
chemical_list: D000975:Antioxidants; D004232:Diuretics; D020030:Nitric Oxide Donors; D010975:Platelet Aggregation Inhibitors; D011372:Progestins; D011374:Progesterone; D002118:Calcium